Page URL:

More women get tested for breast cancer genes thanks to 'Angelina Jolie effect'

19 December 2016
Appeared in BioNews 882

Angelina Jolie's 2013 public announcement that she has the BRCA1 breast cancer gene led to a 64 percent increase in women seeking genetic testing for breast cancer, according to a new analysis.

However, the rate of preventative mastectomies following testing went down, suggesting that her announcement did not reach those women most at risk.

Back in 2013, the actress wrote an editorial in the New York Times describing how she had tested positive for the BRCA1 mutation and that she had decided to have a double mastectomy to avoid breast cancer. She encouraged other at risk women to get tested. Now, a study published in the BMJ has investigated the effect of her announcement.

'Her editorial was very effective in terms of raising awareness about this test, which had not been widely used at the time,' said Dr Sunita Desai of Harvard Medical School, who was a co-author of the study.

The rates of BRCA1 and BRCA2 testing and mastectomy were analysed in 100,000 US women 15 days before and 15 days after Jolie's publication on 14 May 2013. The researchers also compared mastectomy rates before and after the editorial, overall, and in 60 days after gene testing.

Although there was a 64 percent increase in daily BRCA tests, there was no rise in the rates of mastectomy. In fact, the surgery rate fell from ten to seven percent.

'We feel that this suggests that women who underwent BRCA testing as a result of the editorial had fewer risk factors and so a lower probability of having the BRCA mutation than women tested before the editorial,' said Dr Desai.

Jasmine Just, health information officer at Cancer Research UK, said that celebrities can influence the people by promoting their understanding of cancer and how to prevent the disease: '[But] the results suggest the extra tests did not result in finding more women at a higher risk and who therefore could benefit from preventive surgery. So, while celebrities can help reach a lot of people, they may not necessarily reach the group of people who most need the information.'  
7 June 2021 - by Dr Charlott Repschlager 
A targeted breast cancer treatment reduces the risk of BRCA-related cancer returning or spreading after chemotherapy...
17 September 2018 - by Dr Melanie Krause 
A new and faster way to evaluate the pathogenicity of different variants of a breast-cancer related gene has been developed using CRISPR genome editing...
16 October 2017 - by Dr Hannah Somers 
A new genetic test to accurately predict an individual's risk of developing breast cancer will soon be rolled out at two hospital clinics in Manchester...
26 June 2017 - by Dr Lea Goetz 
A study of almost 10,000 women carrying BRCA mutations has revealed the best estimate yet of their risk in developing breast and ovarian cancer...
20 March 2017 - by Dr Molly Godfrey 
A genetic study of breast cancer patients suggests that existing drugs for treating rare breast and ovarian cancers may help more patients than previously thought...
22 February 2016 - by Dr Helen Robertson 
More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...
8 June 2015 - by Jenny Sharpe 
Researchers have called for mass screening of women in their 30s to detect cancer-causing mutations...
30 March 2015 - by Sophie McLachlan 
In an article in the New York Times, Angelina Jolie has revealed her decision to have her ovaries and fallopian tubes removed, in her on-going battle to reduce her risk of cancer...
22 September 2014 - by Jessica Ware 
The number of women in the UK being referred to breast cancer clinics doubled shortly after actress Angelina Jolie revealed she had a risk-reducing double mastectomy, a study has found....
8 September 2014 - by Dr Kimberley Bryon-Dodd 
Angelina Jolie's decision to openly discuss her preventative double mastectomy after testing positive for a dangerous BRCA1 mutation may have led to a dramatic upswing in referrals to genetic counselling services, if results from a Canadian study are widely applicable...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.